Delivery Order SPE2DB24D2205-SPE2DB24FDVVK
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,056.20 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, on May 21, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a ceiling value of $1,149.84 and a completion date of July 8, 2024. It is a firm fixed-price delivery order contract awarded without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,739.30, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on May 3, 2024, with a completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award is for the delivery of REXULTI 3 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 8, 2024 with a completion date of March 11, 2024. The contract has a firm fixed-price ceiling value of $39,575.06. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $14,650.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract award is not associated with a set-aside designation, indicating open...
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $5,810.14 and an ultimate completion date of April 22, 2024....
This federal contract award is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $36,201.18, was awarded to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, on September 5, 2024. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 6, 2024. There is no set-aside designation mentioned for this contract....
This federal contract award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,831.84 and a completion date of December 20, 2024. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,547.92 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024. The contract is a delivery order with a firm fixed price and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of...
This federal contract award is for the delivery of REXULTI 0.5 MG TABLET 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $6,034.90 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 11, 2023 and was awarded on May 10, 2023. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...